ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,711Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 122

$423K Total Retail Price of All Prescriptions

Rank: 26 out of 122

352 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 352 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

3% of this provider’s 352 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 5,945 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
SIMVASTATIN 474 384 1 1
OMEPRAZOLE 375 315 2 3
AMLODIPINE BESYLATE 373 338 3 7
LISINOPRIL 310 265 4 2
HYDROCHLOROTHIAZIDE 275 241 5 6
FUROSEMIDE 222 155 6 5
LEVOTHYROXINE SODIUM 216 183 7 4
METOPROLOL TARTRATE 202 176 8 8
WARFARIN SODIUM 155 123 9 9
ATORVASTATIN CALCIUM 153 143 10 13
NEXIUM 146 108 11 32
SERTRALINE HCL 112 83 12 18
GABAPENTIN 102 74 13 12
METOPROLOL SUCCINATE 102 95 13 11
PANTOPRAZOLE SODIUM 99 69 15 23
TRAMADOL HCL 96 67 16 20
METFORMIN HCL 95 82 17 14
ADVAIR DISKUS 88 73 18 34
KLOR-CON M20 84 68 19 67
ATENOLOL 78 78 20 10
RANITIDINE HCL 69 33 21 39
CITALOPRAM HBR 69 27 21 15
ENALAPRIL MALEATE 69 57 21 43
LOSARTAN POTASSIUM 67 67 24 17
VYTORIN 63 59 25 153
ZETIA 62 62 26 84
POTASSIUM CHLORIDE 60 43 27 22
LANTUS 60 48 27 36
ISOSORBIDE MONONITRATE ER 58 58 29 44
ZOLPIDEM TARTRATE 57 34 30 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 49 30 49
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 32 55
CRESTOR 55 49 33 37
SPIRIVA 53 31 34 29
TAMSULOSIN HCL 53 42 34 26
LANTUS SOLOSTAR 52 15 36 57
DOXEPIN HCL 51 29 37 171
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.